Featured Sequencing & Proteomics Solutions
Explore our advanced high-throughput genomics and transcriptomics pipelines designed to complement mass spectrometry-based proteomic studies for comprehensive multi-omics analysis.
The Rise of Mass Spectrometry-Based Proteomics in Indonesia
In recent years, Indonesia's scientific research landscape has undergone a monumental shift toward advanced molecular biology. With the government's centralization of research under the National Research and Innovation Agency (BRIN - Badan Riset dan Inovasi Nasional) and increased funding for academic institutions like Universitas Indonesia (UI), Gadjah Mada University (UGM), and the Bandung Institute of Technology (ITB), the demand for high-end analytical technologies has skyrocketed. Among these, mass spectrometry-based proteomics has emerged as a cornerstone for modern biotechnology, clinical diagnostics, and agricultural optimization.
Proteomics, the large-scale study of proteins, provides an real-time functional map of cellular processes that genomics alone cannot predict. By utilizing advanced mass spectrometry (MS) platforms, researchers across the Indonesian archipelago are now able to profile complex proteomes, identify post-translational modifications, and quantify protein dynamics with unprecedented precision. This technology is vital for driving localized innovation, helping local companies and academic institutions transition from basic research to commercial applications.
Clinical Biomarkers
Accelerating the discovery of diagnostic markers for tropical diseases like Dengue, Tuberculosis, and Malaria native to Southeast Asia.
Agricultural Proteomics
Optimizing crop yields and disease resistance in key Indonesian exports such as oil palm, rubber, coffee, and cacao.
Halal Verification
Deploying highly specific mass spec assays to identify porcine-derived proteins, ensuring strict compliance with local Halal regulations.
Localized Application Scenarios in the Indonesian Market
The unique socio-economic and geographical layout of Indonesia presents specific challenges and opportunities where mass spectrometry-based proteomics plays a transformative role:
1. Biodiverse Marine and Terrestrial Natural Products
Indonesia is one of the world's premier megadiverse nations. Local pharmaceutical and nutraceutical companies are actively mining the country's vast rainforests and marine habitats for novel bioactive compounds. Mass spectrometry allows scientists to perform rapid peptidomics and proteomics screening to isolate therapeutic peptides, venom toxins, and enzyme inhibitors that could lead to the next generation of therapeutics.
2. Oil Palm (Elaeis guineensis) Disease Control
As the world's largest producer of palm oil, Indonesia's agricultural economy relies heavily on crop health. The devastating Basal Stem Rot (BSR) disease, caused by the fungus Ganoderma boninense, cost the industry millions annually. Mass spectrometry-based proteomics is being deployed to study the host-pathogen interaction, identifying early-stage defense proteins in oil palm cultivars to breed resistant strains.
3. Clinical Proteomics and Personalized Medicine
With a population exceeding 270 million, Indonesia faces a double burden of infectious diseases and rising non-communicable chronic conditions like diabetes and cardiovascular disorders. Local clinical research centers are partnering with global providers to obtain competitive mass spectrometry quotes for biomarker discovery pipelines. These efforts aim to create localized diagnostic panels tailored specifically to the genetic and environmental background of the Indonesian population.
Biomarker Technologies (BMKGene) Overview
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Fully Automated Platform for Next-generation sequencing—Brilliant Lab 1000
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.
Advanced Multi-Level High-Throughput Platforms
To support the complex requirements of proteogenomics and integrated multi-omics, BMKGene operates state-of-the-art facilities equipped with industry-leading sequencing and mass spectrometry systems.
Leading Sequencing Platforms
- PacBio platforms: Sequel II, Sequel, RSII
- Nanopore platforms: PromethION P48, GridION X5, MinION
- 10X Genomics: 10X ChromiumX, 10X Chromium Controller
- Illumina platforms: NovaSeq
- BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
- Bionano Irys system
Mass Spectrometry & Lab Scale
- Waters XEVO G2-XS QTOF: High-resolution mass spectrometry for untargeted proteomics and metabolomics.
- QTRAP 6500+: Ultra-sensitive targeted quantitative proteomics (MRM/PRM assays).
- Over 20,000 square feet place: Advanced biomolecular laboratory instruments.
- Standard labs of sample extraction, library construction, clean rooms, and sequencing labs operating under strict SOPs.
Reliable, Easy-to-use On-line Bioinformatic Analysis Platform
Our self-developed BMKCloud platform provides researchers in Indonesia and worldwide with seamless data interpretation capabilities. Powered by CPUs with 41,104 memory and 3 PB total storage, the platform features 4,260 computing cores with peak computing power over 121,708.8 Gflop per second. This enables rapid processing of raw mass spectrometry data and integration with genomic/transcriptomic datasets.
Our State-of-the-Art Facilities
A glimpse inside our automated production lines and high-throughput molecular laboratories designed to ensure maximum precision and rapid turnaround times.
Enterprise Qualifications & Accreditations
BMKGene is committed to maintaining the highest global standards for quality management, environmental safety, and intellectual property. Our operations are fully certified under key international frameworks.
Proprietary Patents & Bioinformatics Copyrights
Continuous R&D is the core driver of our high-quality data outputs. We hold numerous patents covering library construction, sequencing analysis methods, and specialized bioinformatics workflows.
Our Complete Multi-Omics Product Line
Combine our genomic pipelines with your proteomic studies to achieve comprehensive systems biology insights. Get quotes for localized services in Indonesia.
